PuSH - Publication Server of Helmholtz Zentrum München

Bolduan, S. ; Koppensteiner, H. ; Businger, R.* ; Rebensburg, S. ; Kunze, C. ; Brack-Werner, R. ; Draenert, R.* ; Schindler, M.

T cells with low CD2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic HIV-1 patients.

J. Int. AIDS Soc. 20:21865 (2017)
Publ. Version/Full Text DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Bolduan S et al; licensee International AIDS Society. Introduction: Restriction factors (RFs) suppress HIV-1 in cell lines and primary cell models. Hence, RFs might be attractive targets for novel antiviral strategies, but their importance for virus control in vivo is controversial. Methods: We profiled the expression of RFs in primary blood-derived mononuclear cells (PBMC) from therapy-naïve HIV-1 patients and quantified infection. Results: Overall, there was no correlation between individual RF expression and HIV-1 status in total PBMC. However, we identified a T cell population with low levels of intracellular CD2 and reduced expression of SAMHD1, p21 and SerinC5. CD2 low T cells with reduced RF expression were markedly positive for HIV-1 p24. In contrast, CD2+ T cells were less infected and expressed higher levels of RFs. CD2 low T cell infection correlated with viral loads and was associated with HIV-1 disease progression. Conclusions: In untreated therapy naïve chronic HIV-1 patients, RF expression in T cells is associated with CD2 expression and seems to influence viral loads. Our study suggests that RFs help to control HIV-1 infection in certain T cells in vivo and supports the potential for RFs as promising targets for therapeutic intervention.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
6.296
1.352
7
7
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Hiv-1 ; In Vivo Relevance ; P21 ; Restriction Factors ; Risp ; Samhd1 ; Serinc5 ; Tetherin; Hepatitis-c Virus; In-vivo; Antiretroviral Activity; Immunodeficiency-virus; Elite Controllers; Host; Nef; Vpu; Surface; Samhd1
Language
Publication Year 2017
HGF-reported in Year 2017
ISSN (print) / ISBN 1758-2652
e-ISSN 1758-2652
Quellenangaben Volume: 20, Issue: 1, Pages: , Article Number: 21865 Supplement: ,
Publisher Springer
Publishing Place Berlin ; Heidelberg
Reviewing status Peer reviewed
POF-Topic(s) 30203 - Molecular Targets and Therapies
Research field(s) Immune Response and Infection
PSP Element(s) G-502700-006
G-502700-001
PubMed ID 28953327
Scopus ID 85040689833
Erfassungsdatum 2017-09-29